DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 48 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$1,172,993
-66.2%
3,161,707
-54.5%
0.02%
-65.2%
Q3 2022$3,475,000
-14.4%
6,949,4160.0%0.07%
-17.9%
Q2 2022$4,060,000
-17.9%
6,949,4160.0%0.08%
-24.3%
Q1 2022$4,948,000
-46.1%
6,949,4160.0%0.11%
-42.2%
Q4 2021$9,173,000
-42.6%
6,949,4160.0%0.19%
-38.5%
Q3 2021$15,984,000
-47.6%
6,949,4160.0%0.31%
-42.4%
Q2 2021$30,508,000
-39.5%
6,949,4160.0%0.54%
-48.9%
Q1 2021$50,453,000
+68.1%
6,949,4160.0%1.06%
+78.8%
Q4 2020$30,021,000
+5.1%
6,949,4160.0%0.59%
-14.7%
Q3 2020$28,562,000
-34.4%
6,949,416
-4.3%
0.70%
-45.2%
Q2 2020$43,560,000
-34.7%
7,259,988
-18.1%
1.27%
-40.1%
Q1 2020$66,733,000
-45.2%
8,862,2470.0%2.12%
-45.5%
Q4 2019$121,856,000
+14.9%
8,862,247
-0.7%
3.89%
-10.0%
Q3 2019$106,012,000
-15.1%
8,923,6000.0%4.32%
-3.6%
Q2 2019$124,841,000
-13.0%
8,923,600
+11.2%
4.48%
-18.5%
Q1 2019$143,462,000
+13.7%
8,023,6000.0%5.50%
+8.9%
Q4 2018$126,211,0008,023,6005.05%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders